Track 1: Clinical Pharmacy and Therapeutics

Medication retention is set by the medication's science properties, detailing, and course of organization. Measurement shapes (e.g. tablets, cases, arrangements), comprising of the medication and elective fixings, squaremeasure created to lean by various courses (e.g. oral, buccal, sublingual, rectal, parenteral, topical, inhalational). Regardless of the course of organization, drug ought to be in reply to be ingested. Subsequently, strong structures (e.g. tablets) ought to have the capacity to crumble and disaggregate. Furthermore, Route of Administration in medication and pharmacological prescription is that the way by that a medication, liquid, toxin, or elective substance is taken into the body. Courses of organization square measure commonly characterized by the position at that the substance is connected. Basic illustrations exemplify oral and endovenous organization. Impacts of Disease on pharmaceutical medication demeanor allude to all procedures worried inside the ingestion, dispersion digestion and discharge of prescription in an exceedingly living being.

 

Pharmaceutical Societies in USA: Parenteral Drug Association, National Association of Drug Diversion Investigators, Inc. (NADDI), Drug & Alcohol Testing Industry Association (DATIA), Association for Accessible Medicines (AAM), U.S. Food and Drug Administration, International Federation of Pharmaceutical Manufaturers & Associations, Drug Information Association, National Institute on Drug Abuse (NIDA), National Association of Drug Court Professionals, Consumer Healthcare Products Association

Clinical trials and drug information

• Outcome research and pharmacoeconomic studies
• Clinical case studies
• Role of pharmacist in communicating and counseling patients
• Clinical genomics and proteomics
• Risks and benefits of drug therapy
• Preparation of personalized formulation
• Therapeutic drug monitoring
• Influence of national and formulating policies in drug development
• Pharmacy Clinical Services

Track 2: Drug Targeting and Design

The most essential objective in sedate outline is to foresee whether a given atom will tie to an objective and if so how firmly. Atomic mechanics or sub-atomic elements are frequently used to foresee the adaptation of the little particle and to show conformational changes in the organic focus on that may happen when the little atom ties to it. The helpful reaction of a medication relies on the collaboration of medication atoms with cell on cell film related organic occasions at receptor destinations in fixation subordinate way. Specific and successful confinement of the pharmacologically-dynamic moiety at pre-distinguished target(s) in restorative focus, while limiting its entrance to non-target(s) typical cell linings, hence limiting lethal impacts and expanding the helpful list accounts from powerful and effective medication conveyance.

Drug Delivery Societies in Europe: Austrian Pharmaceutical Society, Croatian Pharmaceutical Society, Czech Pharmaceutical Society, European Pharmaceutical Students Association, FIGON - Netherlands Federation for Innovative Drug Research, Finnish Pharmaceutical Society, German Pharmaceutical Society (DPhG), Hellenic Pharmaceutical Society and Hungarian Society for Pharmaceutical Sciences (HSPS)

 

Rational Drug Design

• Computer Aided Drug Design
• Drug Design Theory
• Role of Computers in Drug Design: Their Success and Failure
• Rational Drug Design Software
• RACHEL Software Package
• Factors influencing Drug Targeting
• Advances in Drug Targeting components
• Recent Approaches to Drug Targeting

Track 3: Industrial Pharmacy

Mechanical Pharmacyadditionally assumes an essential part in any medication revelation. To any novel medication revelation the modern approach is essential to get monstrous business application. Barely any things which must be considered by enterprises to give a safe and cost emotional solution to the patients like Supply chain, Waste administration, Product administration, Post-promoting reconnaissance, Good assembling practices and Marketing.

• Post- marketing surveillance
• Good manufacturing practices
• Pharmaceutical Marketing

Drug Delivery Societies in Asia and Pacific: Indian Pharmaceutical Association, Indian Drug Manufacturers' Association and Bulk Drug Manufacturers Association

Track 4: Hospital Pharmacy

They are specialists in the field of pharmaceuticals and are in charge of the administering of solutions as well as the buy, fabricate and quality testing of all prescriptions utilized as a part of a healing facility. Numerous doctor's facility drug specialists are fit the bill to endorse in their own particular right. Drug specialists work intimately with therapeutic and nursing staff to guarantee that patients get the best treatment, prompting on the choice, dosage and organization course. They additionally give assistance and guidance to patients in all parts of their meds.

• Drug Interactions
• Industrial pharmaceutics
• Pre-clinical studies
• Clinical studies

Pharmaceutical Societies in USA: Parenteral Drug Association, National Association of Drug Diversion Investigators, Inc. (NADDI), Drug & Alcohol Testing Industry Association (DATIA), Association for Accessible Medicines (AAM), U.S. Food and Drug Administration, International Federation of Pharmaceutical Manufaturers & Associations, Drug Information Association, National Institute on Drug Abuse (NIDA), National Association of Drug Court Professionals, Consumer Healthcare Products Association

Track 5: Pharmaceutical Sciences

The pharmaceutical sciences consolidate expansive scope of logical orders that are basic to the revelation and advancement of new medications and treatments. Pharmaceutical Sciences is a dynamic and interdisciplinary field that plans to incorporate key standards of physical and natural science, designing, organic chemistry, and science to see how to streamline conveyance of medications to the body and make an interpretation of this coordinated comprehension into better than ever treatments against human infection. 

• Drug Designing and Targeting
• Routes of Drug Delivery
• PK-PD
• Bioavailability and Bioequivalence

Drug Delivery Societies in Europe: Austrian Pharmaceutical Society, Croatian Pharmaceutical Society, Czech Pharmaceutical Society, European Pharmaceutical Students Association, FIGON - Netherlands Federation for Innovative Drug Research, Finnish Pharmaceutical Society, German Pharmaceutical Society (DPhG), Hellenic Pharmaceutical Society and Hungarian Society for Pharmaceutical Sciences (HSPS)

Basically, it includes compound parts of recognizable proof, and after that efficient, intensive engineered change of new concoction elements to make them reasonable for restorative utilize. It incorporates engineered and computational parts of the investigation of existing medications and specialists being developed in connection to their bioactivities i.e., understanding their structure-action connections (SAR). Pharmaceutical science is centered around quality parts of solutions and means to guarantee wellness for reason for restorative items.

• Protein structure prediction and molecular simulation
• Biochemistry
• Exploratory development
• Phytotherapy & Complementary medicine
• Protein structure prediction and molecular simulation

Pharmaceutical Societies in USA: Parenteral Drug Association, National Association of Drug Diversion Investigators, Inc. (NADDI), Drug & Alcohol Testing Industry Association (DATIA), Association for Accessible Medicines (AAM), U.S. Food and Drug Administration, International Federation of Pharmaceutical Manufaturers & Associations, Drug Information Association, National Institute on Drug Abuse (NIDA), National Association of Drug Court Professionals, Consumer Healthcare Products Association

Track 7: Pharmacological Science

Pharmacology is the investigation of the biochemical and physiological impacts of dynamic fixing on people. The different parts of pharmacological sciences are Behavioral pharmacology, Medical Pharmacology, Cardiovascular pharmacology, Endocrine pharmacology, Clinical pharmacology, Urogenital pharmacology, Pharmacokinetics, Neuropharmacology, Immune pharmacology, Cognitive models of the cerebrum, Neural models of memory, .

• Behavioral pharmacology
• Cardiovascular Pharmacology
• Cognitive neuroscience and neurosystems
• Neuropsychology
• Functional modes of the brain
• Endocrine pharmacology
• Clinical Pharmacology

• Drug Delivery Societies in Asia and Pacific: Indian Pharmaceutical Association, Indian Drug Manufacturers' Association and Bulk Drug Manufacturers Association

• Track 08: Generic drugs, generic pills and generic medication

A nonexclusive drug (nonspecific solutions, short: generics medicines) is a prescription described as "a pharmaceutical thing that is commensurate to a brand/reference recorded solution thing in estimations outline, quality, quality and execution characteristics, and arranged use." It has in like manner been portrayed as a term implying any meds displayed under its invention name without publicizing or to the compound beauty care products of a non specific prescription rather than the advanced check name under which the medicine is sold.  

• Generic drug manufacturing
• Generic drugs Europe

• Pharmaceutical Societies in USA: Parenteral Drug Association, National Association of Drug Diversion Investigators, Inc. (NADDI), Drug & Alcohol Testing Industry Association (DATIA), Association for Accessible Medicines (AAM), U.S. Food and Drug Administration, International Federation of Pharmaceutical Manufaturers & Associations, Drug Information Association, National Institute on Drug Abuse (NIDA), National Association of Drug Court Professionals, Consumer Healthcare Products Association\  

• Track 09: Biosimilar and biologics

Biosimilars the Generic type of natural is the new mainstream articulation in pharmaceutical industry. Biosimilars are outstandingly similar to approved reference thing not withstanding minor differences in clinically sit out of gear parts; moreover there are no clinically huge differentiations between the natural and the reference thing to the extent prosperity, ideals, and quality. This joins: Licensing of Biosimilars, Biomarkers course, Patent issues, BLA requesting of for Biosimilars, Regulatory prospects of BRIC countries, a perspective of standard generics to Biosimilars, Biologics& Bio waiver support for Biosimilars and distinctive parts of Biosimilar supports.

• Bio-analytics for Biosimilars
• Extrapolation and Interchangeability

Drug Delivery Societies in Europe: Austrian Pharmaceutical Society, Croatian Pharmaceutical Society, Czech Pharmaceutical Society, European Pharmaceutical Students Association, FIGON - Netherlands Federation for Innovative Drug Research, Finnish Pharmaceutical Society, German Pharmaceutical Society (DPhG), Hellenic Pharmaceutical Society and Hungarian Society for Pharmaceutical Sciences (HSPS)

Track 10: Generics and biosimilars industry strategy

The "Nonexclusive Drugs Market: 2015 - 2030 - Opportunities, Challenges, Strategies and Forecasts" report exhibits a top to bottom evaluation of the non specific medications and Analysis of key remedial regions and driving non specific medications pufecosystem including innovation, financial aspects, key patterns, showcase drivers, challenges, venture potential, administrative scene, driving treatments, Pharmaceutical Industry openings, future guide, Following key patterns, advertise drivers, challenges, Analysis of key restorative territories and driving bland patterns ,esteem chain, biological community player profiles and systems and Regulatory scene of worldwide patterns all through the globe The report likewise introduces advertise measure estimates for non specific medications from 2017 through to 2030. The estimates are sectioned for more than 10 helpful territories, 3 mark groupings, 5 locales and 25 driving nations.

• Clinical development strategies for biosimilars
• Advances in Biosimilar Production & Technologies
• Scale Up of Biosimilars

Pharmaceutical Societies in USA: Parenteral Drug Association, National Association of Drug Diversion Investigators, Inc. (NADDI), Drug & Alcohol Testing Industry Association (DATIA), Association for Accessible Medicines (AAM), U.S. Food and Drug Administration, International Federation of Pharmaceutical Manufaturers & Associations, Drug Information Association, National Institute on Drug Abuse (NIDA), National Association of Drug Court Professionals, Consumer Healthcare Products Association

Track 11: Nanobiotechnology

We understand that nano oversees matter on a little scale. Nanotechnology is the examination of structures between 1 nanometer and 100 nanometers in measure, greater than particles and molecules, anyway smaller than a breadcrumb. It incorporates into applying various nano-instruments which is appropriate to therapeutic and common issues. That is in light of the fact that in its pushed shape it will have basic impact on all endeavors and all locales of society. Nanotechnology is similarly suggested used as ageneral-reason development, and it incorporate the ability to see and to control solitary particles and particles.

• Analysis of nano biotech drugs
• Current researches in nano technology
• Nano analysis of nano drugs
• Materials
• Applications of nanotechnology

Drug Delivery Societies in Europe:

Austrian Pharmaceutical Society, Croatian Pharmaceutical Society, Czech Pharmaceutical Society, European Pharmaceutical Students Association, FIGON - Netherlands Federation for Innovative Drug Research, Finnish Pharmaceutical Society, German Pharmaceutical Society (DPhG), Hellenic Pharmaceutical Society and Hungarian Society for Pharmaceutical Sciences (HSPS)

Track 12: Advanced Nanomedicine

Progressed Nanomedicine is just the nanotechnology applications in a human services setting and the greater part of advantages that have just been seen include the utilization of nanoparticles to enhance the conduct of medication substances and in tranquilize conveyance. Today, nanomedicines are utilized all around to enhance the medications and lives of patients experiencing a scope of clutters including ovarian and bosom growth, kidney malady, contagious diseases, lifted cholesterol, menopausal indications, different sclerosis, endless torment, asthma and emphysema. Nanomedicine can possibly create radical new treatments in light of a phenomenal control over both intracellular procedures and the extracellular condition at the nanometer scale.  

• Scope of Nanomedicine
• Nanodrugs for Herbal medicines and Cosmetics
• Novel Drugs to Nano Drugs

Drug Delivery Societies in Asia and Pacific:

Indian Pharmaceutical Association, Indian Drug Manufacturers' Association

 Track 13: Design of Nanodrugs

Nanodrugs phenomenal advances in nanotechnology and nanoscience have been accompanied by exciting progress in de novo design of nano sized drugs. Nanoparticles with their large space of structural amenability and excellent mechanical and electrical properties have become ideal candidates for high efficacy nanomedicines in both diagnostics and therapeutics. The therapeutic nanomedicines can be further categorized into nanoparticle drug delivery for conventional drugs and nanodrugs and nanobots with direct curing of target diseases. Here we review some of the recent advances in de novo design of nanodrugs, with an emphasis on the molecular level understanding of their interactions with biological systems including key proteins and cell membranes. We also include some of the latest advances in the development of nanocarriers with both passive and active targeting for completeness. These studies may shed light on a better understanding of the molecular mechanisms behind these nanodrugs , formulations of drugs , and also provide new insights and direction for the future design of nanomedicines.

• Nano Sized Drugs
• Nanodrugs for Cancer Therapy
• Novel Drugs to Nano Drugs
• Pharmaceutical Societies in USA
• : Parenteral Drug Association, National Association of Drug Diversion Investigators, Inc. (NADDI), Drug & Alcohol Testing Industry Association(DATIA), Association for Accessible Medicines (AAM), U.S. Food and Drug Administration, International Federation of Pharmaceutical Manufaturers & Associations, Drug Information Association, National Institute on Drug Abuse (NIDA), National Association of Drug Court Professionals, Consumer Healthcare Products Association

Track 14:  Recent Nanomaterials for drug delivery

Medication conveyance frameworks showcase is extending quickly. The same number of new medications require novel and creative medication conveyance methods. The advancement of such medication conveyance frameworks can enhance existing medications' restorative adequacy, easing their reactions, and diminishing the cost. Being helpful from the quick advance of nanotechnologies and nanomaterials amid a decades ago, many propelled sedate conveyance frameworks have been made conceivable.

• Nanomaterials for Imaging
• Biocompatible nanomaterials
• Polymeric nanocomposites
• Techniques for characterization in nanotechnology
• Advanced Nanomaterials
• Nanomaterials for Diagnostics
• Materials for Theranostics

Drug Delivery Societies in Europe: Austrian Pharmaceutical Society, Croatian Pharmaceutical Society, Czech Pharmaceutical Society, European Pharmaceutical Students Association, FIGON - Netherlands Federation for Innovative Drug Research, Finnish Pharmaceutical Society, German Pharmaceutical Society (DPhG), Hellenic Pharmaceutical Society and Hungarian Society for Pharmaceutical Sciences (HSPS)

Track 15: Emerging technologies on Nanomedicine and Nanotechnology

Nanomedicine is the restorative utilization of nanotechnology. Nanomedicine ranges from the therapeutic uses of nanomaterials and organic gadgets, to nanoelectronic biosensors, and even conceivable future utilizations of sub-atomic nanotechnology, for example, natural machines. Utilizing nanoparticle differentiate operators, pictures, for example, ultrasound and MRI have a great circulation and enhanced difference. This may be refined without anyone else's input gathered biocompatible nanodevices that will recognize, assess, treat and answer to the clinical specialist consequently. Nanotechnology("nanotech") is control of issue on a nuclear, atomic, and supramolecular scale.  . 

• Carbon Nanotubes
• Nanoparticles
• Gold Nanoparticles
• Silver Nanoparticles

Drug Delivery Societies in Asia and Pacific: Indian Pharmaceutical Association, Indian Drug Manufacturers' Association and Bulk Drug Manufacturers Association

Track 16: Synthesis of Nanoparticles for Drug Delivery

Nanoparticle innovation was as of late appeared to hold extraordinary guarantee for sedate conveyance applications in nanomedicine because of its helpful properties, for example, better exemplification, bioavailability, control discharge, and lower dangerous impact. In spite of the immense advance in nanomedicine, there stay numerous confinements for clinical applications on nanocarriers.Synthesizing nanoparticles for pharmaceutical purposes, for example, tranquilize readiness should be possible in two techniques. Base up process, for example, pyrolysis, dormant gas buildup, solvothermal response, sol-gel manufacture and organized media in which hydrophobic compound, for example, liposomes are utilized as bases to mount the medication. 

• Solid Lipid Nanoparticles
• Polymeric Nanoparticles

Pharmaceutical Societies in USA:

Parenteral Drug Association, National Association of Drug Diversion Investigators, Inc. (NADDI), Drug & Alcohol Testing Industry Association (DATIA), Association for Accessible Medicines (AAM), U.S. Food and Drug Administration, International Federation of Pharmaceutical Manufaturers & Associations, Drug Information Association, National Institute on Drug Abuse (NIDA), National Association of Drug Court Professionals, Consumer Healthcare Products Association

Track 17: Nano Pharmaceuticals

Nano pharmaceuticals offer the capacity to recognize maladies at significantly prior stages and the analytic applications could expand upon customary methods utilizing nanoparticles. Nano pharmaceuticals speak to a developing field where the sizes of the medication molecule or a remedial conveyance framework work at the Nano scale. In the pharmaceutical business, a long standing issue is the trouble of conveying the suitable measurement of a specific dynamic specialist to particular infection site.

• Drug Targeting
• Challenges and advances in NanoPharmaceuticals

• Pharmaceutical Societies in USA: Parenteral Drug Association, National Association of Drug Diversion Investigators, Inc. (NADDI), Drug & Alcohol Testing Industry Association (DATIA), Association for Accessible Medicines (AAM), U.S. Food and Drug Administration, International Federation of Pharmaceutical Manufaturers & Associations, Drug Information Association, National Institute on Drug Abuse (NIDA), National Association of Drug Court Professionals, Consumer Healthcare Products Association

Track 18: Molecular Pharmacoepidemiology

Sub-atomic Pharmacoepidemiology is the examination of the manner by which sub-nuclear biomarkers change the clinical effects of solutions in like manner individuals. So also as the basic investigation of Pharmacoepidemiology is the investigation of malady transmission, associated with the substance region of clinical pharmacology, the principal specialty of nuclear Pharmacoepidemiology is the investigation of infection transmission when all is said in done and sub-nuclear the investigation of sickness transmission especially, in like manner associated with the substance district of clinical pharmacology. 

• Molecular & Cellular Pharmacology
• Infectious Disease Epidemiology
• Epidemiology of Aging
• Clinical Epidemiology
• Neuro-Psychiatric Epidemiology
• Origins and Types of Antibiotic and Antimicrobials
• Bacterial Spectrum
• Route of Administration
• Type of Activity

Pharmaceutical Societies in USA: Parenteral Drug Association, National Association of Drug Diversion Investigators, Inc. (NADDI), Drug & Alcohol Testing Industry Association (DATIA), Association for Accessible Medicines (AAM), U.S. Food and Drug Administration, International Federation of Pharmaceutical Manufaturers & Associations, Drug Information Association, National Institute on Drug Abuse (NIDA), National Association of Drug Court Professionals, Consumer Healthcare Products Association

According to IMS Health Consulting, an international research company, in 2012 the size of the global pharmaceutical market reached $940 billion. In monetary terms it grew by 6%. In the future the sector is expected to grow at no less than 3% to 4% a year and if this happens the global pharmaceutical market is expected to reach $1.1 trillion by 2015 and will reach $1.2 trillion in 2016 and up to $1.5 trillion by 2020. The global demographic, epidemiological and economic changes are transforming the pharmaceutical market.

The pharmaceutical industry is directly impacted by the research conducted with prescription drugs, vaccines, and OTC drugs being manufactured based on findings from the study of life sciences. The world population is growing rapidly and is projected to raise from 7 billion in 2011 to 7.7 billion in 2020 and 9.6 billion in 2050, hence an increase in the demand for pharmaceuticals. The ageing process also affects the demand. By 2020 about 9.4% of the world population (719.4 million people) will be 65 or above, compared with 7.3% (477.4 million) in 2005 (UN, 2013). Clinical advances reinforce this trend. The improvements of the past few decades have already converted some previously terminal illnesses into chronic conditions, thus increasing long-term demand for pharma-co-therapeutics to manage these diseases. Spending on medicines will reach nearly $1,100Bn in 2015, reflecting a slowing growth rate of 3-6% over the five year period compared to 6.2% annual growth over the past five years. Absolute global spending growth is expected to be $210-240Bn, compared to $251Bn since m2005.